Shorter or longer prednisolone for lung sarcoidosis?
Treatments studied
Part of Blood & lymphatic, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This trial compares two treatment durations—12 months versus 6 months—of the steroid prednisolone for people with lung sarcoidosis. It aims to see if a shorter course works just as well while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a confirmed diagnosis of sarcoidosis in your lungs (or nearby lymph nodes) based on a CT scan and tissue sample.
- You have symptoms that need treatment, or your lung function is below 80% of normal, or sarcoidosis has affected other parts of your body.
- Your symptoms started within the last two years.
- You do not have severe sarcoidosis in your brain, heart, or eyes that requires high-dose steroids.
- You do not have untreated glaucoma, uncontrolled diabetes, an active infection, or a severe untreated psychiatric condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if people with stable sarcoidosis can safely lower their corticosteroid dose over time. It may help reduce side effects from long-term steroid use.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This study looks at how the immune system works in people with sarcoidosis. It may help researchers find better ways to diagnose or treat the disease in the future.
This trial studies whether sirolimus (an immune-influencing medicine) can improve moderate-to-severe sarcoidosis affecting the face. It may help if you’ve tried standard sarcoidosis treatments before but they didn’t work well enough or stopped working.
This trial tests whether nintedanib, a drug that slows lung scarring, can help people with sarcoidosis-related lung fibrosis. It is for those who still have breathlessness or cough despite stable treatment.
This trial tests if a steroid combination medicine called Compound Betamethasone works well for people recently diagnosed with pulmonary sarcoidosis who haven't yet had treatment. The goal is to see if it can control the disease with fewer side effects than usual steroids.
Hear when a new Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.